INDEMNIFICATION AGREEMENTIndemnification Agreement • March 12th, 2018 • Akebia Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of __________________ by and between Akebia Therapeutics, Inc., a Delaware corporation (the “Company”), and ________________ (“Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering the subject matter of this Agreement.
Officer Restricted Stock Unit AwardOfficer Restricted Stock Unit Award • March 12th, 2018 • Akebia Therapeutics, Inc. • Pharmaceutical preparations
This agreement (the “Agreement”) evidences the grant of a restricted stock unit award by Akebia Therapeutics, Inc. (the “Company”) to the undersigned (the “Participant”), pursuant to and subject to the terms of the Akebia Therapeutics, Inc. 2014 Incentive Plan (as amended from time to time, the “Plan”). For purposes of this Agreement, the “Grant Date” will mean [●].
FOURTH AMENDMENT TO LEASELease • March 12th, 2018 • Akebia Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
This FOURTH AMENDMENT TO LEASE (this "Amendment") is entered into as of May 1, 2017 (the "Effective Date"), by and between CLPF-CAMBRIDGE SCIENCE CENTER, LLC, a Delaware limited liability company ("Landlord"), and AKEBIA THERAPEUTICS, INC., a Delaware corporation ("Tenant").
AMENDMENT NO. 1 TO FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • March 12th, 2018 • Akebia Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDMENT NO. 1 TO FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Amendment”) is made and entered into as of June 28, 2017, by and among Akebia Therapeutics, Inc., a Delaware corporation (the “Company”), the existing stockholders of the Company set forth on the signature pages hereto, and Satter Medical Technology Partners, L.P., a Delaware limited partnership (“SMTP”).
